These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2578312)

  • 1. Transcriptional regulation of c-myc during chemically induced differentiation of HL-60 cultures.
    Grosso LE; Pitot HC
    Cancer Res; 1985 Feb; 45(2):847-50. PubMed ID: 2578312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin structure of the c-myc gene in HL-60 cells during alterations of transcriptional activity.
    Grosso LE; Pitot HC
    Cancer Res; 1985 Oct; 45(10):5035-41. PubMed ID: 3861242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes.
    Gailani D; Cadwell FJ; O'Donnell PS; Hromas RA; Macfarlane DE
    Cancer Res; 1989 Oct; 49(19):5329-33. PubMed ID: 2670202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered regulation of c-myc in an HL-60 differentiation resistant subclone, HL-60-1E3.
    Ely CM; Leftwich JA; Chenevix-Trench G; Hall RE; Westin EH
    Cancer Res; 1987 Sep; 47(17):4595-600. PubMed ID: 3476196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of c-myc expression to differentiation and proliferation of HL-60 cells.
    Filmus J; Buick RN
    Cancer Res; 1985 Feb; 45(2):822-5. PubMed ID: 3855381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased c-myc RNA levels associated with the precommitment state during HL-60 myeloid differentiation.
    Yen A; Guernsey DL
    Cancer Res; 1986 Aug; 46(8):4156-61. PubMed ID: 3460694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
    Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
    J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60).
    Kraft AS; Baker VV; May WS
    Oncogene; 1987 May; 1(2):111-8. PubMed ID: 3325877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The level of c-myc transcript in differentiation-defective mouse erythroleukemia cells.
    Sasaki H; Watanabe T; Nomura S; Oishi M
    Jpn J Cancer Res; 1987 Aug; 78(8):776-9. PubMed ID: 3115922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of DNA synthesis by an inducer of differentiation of leukemic cells, 1 alpha, 25 dihydroxy vitamin D3, precedes down regulation of the c-myc gene.
    Brelvi ZS; Studzinski GP
    J Cell Physiol; 1986 Aug; 128(2):171-9. PubMed ID: 3755442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
    Darling D; Tavassoli M; Linskens MH; Farzaneh F
    Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine.
    Yen A; Forbes ME
    Cancer Res; 1990 Mar; 50(5):1411-20. PubMed ID: 2302706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression.
    Re GG; Antoun GR; Zipf TF
    Oncogene; 1990 Aug; 5(8):1247-50. PubMed ID: 1697411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc.
    Larsson LG; Pettersson M; Oberg F; Nilsson K; Lüscher B
    Oncogene; 1994 Apr; 9(4):1247-52. PubMed ID: 8134128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DMSO-like rapid decrease in c-myc and c-myb mRNA levels and induction of differentiation in HL-60 cells by the anthracycline antitumor antibiotic aclarubicin.
    Stöcker U; Schaefer A; Marquardt H
    Leukemia; 1995 Jan; 9(1):146-54. PubMed ID: 7845009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of gene expression of myeloperoxidase during myeloid differentiation.
    Tobler A; Miller CW; Johnson KR; Selsted ME; Rovera G; Koeffler HP
    J Cell Physiol; 1988 Aug; 136(2):215-25. PubMed ID: 2842344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of irreversibility of granulocytic differentiation induced by dimethyl sulfoxide in HL-60 sublines with a homogeneously staining region.
    Kitajima K; Haque M; Nakamura H; Hirano T; Utiyama H
    Biochem Biophys Res Commun; 2001 Nov; 288(5):1182-7. PubMed ID: 11700036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Decrease of insulin binding to human acute leukemic cells during chemically induced differentiation].
    Palumbo A; Turco GL; Brossa C; D'Alberto M; Ghezzo F; Pegoraro L
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1350-4. PubMed ID: 7004463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.